Lipid rafts and clusters of apoptotic signalling molecule-enriched rafts in cancer therapy Mollinedo F, Gajate C. Future Oncology 6: 811-821. FI: 2.455 (Q3) Lipid raft-targeted therapy in multiple myeloma Mollinedo F, de la Iglesia-Vicente J, Gajate C, Estella-Hermoso de Mendoza A, Villa-Pulgarin JA, Campanero MA, Blanco-Prieto MJ. Oncogene 29: 3748-3757. FI: 7.414 (Q1) Synthesis and cytotoxic activity of a new potential DNA bisintercalator: 1,4-Bis(3-[N-(4-chlorobenzo[g] phthalazin-1-yl) aminopropyl]) piperazine Galisteo J, Navarro P, Campayo L, Yunta MJ, Gómez-Contreras F, Villa-Pulgarin JA, Sierra BG, Mollinedo F, Gonzalez J, Garcia-España E. Bioorganic & medicinal chemistry 18:5301-5309. FI: 2.978 (Q2) Prenylflavonoids and prenyl/alkyl-phloroacetophenones: Synthesis and antitumour biological evaluation Basabe P, de Román M, Marcos IS, Diez D, Blanco A, Bodero O, Mollinedo F, Sierra BG, Urones JG. European Journal of Medicinal Chemistry 45:4258-4269. FI: 3.193 (Q1) Antitumor activity of new hydridotris (pyrazolyl) borate ruthenium(II) complexes containing the phosphanes PTA and 1-CH3¿PTA García-Fernández A, Díez J, Manteca A, Sánchez J, García-Navas R, Sierra BG, Mollinedo F, Gamasa MP, Lastra E. Dalton Transactions 39:10186-10196. FI: 3.647 (Q1) Selective fusion of azurophilic granules with Leishmania-containing phagosomes in human neutrophils Mollinedo F, Janssen H, de la Iglesia-Vicente J, Villa-Pulgarin JA, Calafat J. Journal of Biological Chemistry 285:34528-34536. FI: 5.328 (Q1) Edelfosine-induced metabolic changes in cancer cells that precede the overproduction of reactive oxygen species and apoptosis Selivanov VA, Vizan P, Mollinedo F, Fan TW, Lee PW, Cascante M. BMC Systems Biology 4:135-146. FI: 3.565 (Q1) Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells Burgeiro A, Gajate C, Dakir EH, Villa-Pulagrín JA, Oliveira PJ, Mollinedo F. Anti-Cancer Drugs 22:507-518. FI: 2.376 (Q2) Modeling metastasis biology and therapy in real time in the mouse lung Mendoza A, Hong SH, Osborne T, Khan MA, Campbell K, Briggs J, Eleswarapu A, Buquo L, Ren L, Hewitt SM, Dakir el H, Garfield S, Walker R, Merlino G, Green JE, Hunter KW, Wakefield LM, Khanna C. The Journal of Clinical Investigation 120:2979-88. FI: 15.387 (Q1) Antitumor ether lipids: proapoptotic agents with multiple therapeutic indications Mollinedo F. Expert Opinion on Therapeutic Patents 17:385-405. FI: 1.28 (Q2)
|
